NEW YORK (Genomeweb News) – The board of directors of PerkinElmer has declared a quarterly dividend of $.07 per share.

The dividend is payable on May 7 to shareholders of record as of the close of business on April 16.

PerkinElmer is scheduled to release its fourth-quarter and full-year 2009 results on Feb. 4. Analysts expect, on average, the firm to report Q4 revenues of $479.5 million and earnings per share of $.41.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.